Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 50090-6840

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 50090-6840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Fig 1)

Figure 1 (Fig 1)
A line graph comparing mean plasma R-oxybutynin concentration over 24 hours between oxybutynin chloride extended-release tablets 10 mg once daily and oxybutynin 5 mg thrice daily. The x-axis shows time in hours, and the y-axis shows concentration in ng/mL, illustrating concentration changes with error bars.*
FDA Label Image

Figure 2 (Fig 2)

Figure 2 (Fig 2)
A line graph depicting the mean R-Oxybutynin plasma concentration (ng/mL) over time (hours). The x-axis represents time in hours, ranging from 0 to 24, while the y-axis shows plasma concentration from 0 to 2 ng/mL. Data points show a peak concentration around 5 hours with error bars indicating variability at each time point.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A horizontal error bar chart comparing 'Oxybutynin chloride extended-release tablets' and 'Placebo.' The chart shows mean values with error bars extending around the data points on a scale ranging approximately from -40 to 40, indicating a measurement comparison between the two groups.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A horizontal error bar chart comparing two data points labeled "Oxybutynin chloride extended-release tablets" and "oxybutynin". The x-axis ranges approximately from -40 to 40, with markers at -20, 0, 20, and 40. The values for both points appear centered near -20 with error bars extending on either side.*
FDA Label Image

Figure 5 (Figure 5)

Figure 5 (Figure 5)
A horizontal error bar chart comparing oxybutynin chloride extended-release tablets and oxybutynin. The chart plots values on an x-axis ranging from -40 to 40, with data points and error bars representing variability for each form.*
FDA Label Image

Label Image (Lbl500906840)

Label Image (Lbl500906840)
Oxybutynin Chloride Extended Release 5 mg tablets packaging label from A-S Medication Solutions. The label indicates the oral dosage form in an extended release tablet, with a quantity of 90 tablets per package. Storage instructions specify keeping at 77 degrees Fahrenheit, protected from moisture and light.*
FDA Label Image
Rising-logo (Rising Logo)
FDA Label Image

Structure (Structural Formula)

Structure (Structural Formula)
Chemical structure of oxybutynin chloride, displayed with molecular bonds and functional groups, including a hydrochloride (HCl) component, consistent with the active ingredient in Oxybutynin Chloride Extended Release tablets 5 mg oral dosage form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.